https://www.statcounter.com/counter/counter.js
Web Analytics
Home » Posts tagged with » Andy Schmeltz
Pfizer lung cancer drug Lorbrena bags US FDA approval

Pfizer lung cancer drug Lorbrena bags US FDA approval

Lorbrena FDA approval : US pharma giant Pfizer has bagged approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib) for anaplastic lymphoma kinase (ALK) positive metastatic non-small cell lung cancer (NSCLC). Lorbrena FDA Approval The FDA approval of Lorbrena is for the ALK-positive NSCLC patient population whose condition has progressed on treatment […]

Astellas, Pfizer score Xtandi FDA approval for non-metastatic CRPC

Xtandi FDA approval : Astellas Pharma and Pfizer said that the US Food and Drug Administration (FDA) has expanded the approval of cancer drug Xtandi (enzalutamide) to be used for treatment of men with non-metastatic castration-resistant prostate cancer (CRPC). The earlier Xtandi FDA approval, which came in 2014, was for the treatment of men with […]

Continue reading …